Russia announced on Tuesday the results of the second interim analysis of data from the Sputnik V Covid-19 vaccine clinical trial, which showed greater than 95% efficacy 42 days after the first dose. Kirill Dmitriev, head of Russia’s RDIF sovereign wealth fund, said that new clinical trial data based on …
Read More »Sputnik V Covid-19 Vaccine 95% Effective, Says Russia
